378 related articles for article (PubMed ID: 14645152)
1. Impaired signaling via the high-affinity IgE receptor in Wiskott-Aldrich syndrome protein-deficient mast cells.
Pivniouk VI; Snapper SB; Kettner A; Alenius H; Laouini D; Falet H; Hartwig J; Alt FW; Geha RS
Int Immunol; 2003 Dec; 15(12):1431-40. PubMed ID: 14645152
[TBL] [Abstract][Full Text] [Related]
2. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b.
Qu X; Sada K; Kyo S; Maeno K; Miah SM; Yamamura H
Blood; 2004 Mar; 103(5):1779-86. PubMed ID: 14604964
[TBL] [Abstract][Full Text] [Related]
4. Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells.
Ishizuka T; Chayama K; Takeda K; Hamelmann E; Terada N; Keller GM; Johnson GL; Gelfand EW
J Immunol; 1999 Feb; 162(4):2087-94. PubMed ID: 9973482
[TBL] [Abstract][Full Text] [Related]
5. Vav1 regulates phospholipase cgamma activation and calcium responses in mast cells.
Manetz TS; Gonzalez-Espinosa C; Arudchandran R; Xirasagar S; Tybulewicz V; Rivera J
Mol Cell Biol; 2001 Jun; 21(11):3763-74. PubMed ID: 11340169
[TBL] [Abstract][Full Text] [Related]
6. Early divergence of Fc epsilon receptor I signals for receptor up-regulation and internalization from degranulation, cytokine production, and survival.
Kitaura J; Xiao W; Maeda-Yamamoto M; Kawakami Y; Lowell CA; Kawakami T
J Immunol; 2004 Oct; 173(7):4317-23. PubMed ID: 15383560
[TBL] [Abstract][Full Text] [Related]
7. The FcepsilonRIbeta immunoreceptor tyrosine-based activation motif exerts inhibitory control on MAPK and IkappaB kinase phosphorylation and mast cell cytokine production.
Furumoto Y; Nunomura S; Terada T; Rivera J; Ra C
J Biol Chem; 2004 Nov; 279(47):49177-87. PubMed ID: 15355979
[TBL] [Abstract][Full Text] [Related]
8. WIP regulates signaling via the high affinity receptor for immunoglobulin E in mast cells.
Kettner A; Kumar L; Antón IM; Sasahara Y; de la Fuente M; Pivniouk VI; Falet H; Hartwig JH; Geha RS
J Exp Med; 2004 Feb; 199(3):357-68. PubMed ID: 14757742
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the antigen-induced activation of rodent mast cells by putative Janus kinase 3 inhibitors WHI-P131 and WHI-P154 in a Janus kinase 3-independent manner.
Linwong W; Hirasawa N; Aoyama S; Hamada H; Saito T; Ohuchi K
Br J Pharmacol; 2005 Jul; 145(6):818-28. PubMed ID: 15852029
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation of Tyr342 in the linker region of Syk is critical for Fc epsilon RI signaling in mast cells.
Zhang J; Berenstein E; Siraganian RP
Mol Cell Biol; 2002 Dec; 22(23):8144-54. PubMed ID: 12417718
[TBL] [Abstract][Full Text] [Related]
11. Structural requirements of SLP-76 in signaling via the high-affinity immunoglobulin E receptor (Fc epsilon RI) in mast cells.
Kettner A; Pivniouk V; Kumar L; Falet H; Lee JS; Mulligan R; Geha RS
Mol Cell Biol; 2003 Apr; 23(7):2395-406. PubMed ID: 12640123
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cbeta.
Nechushtan H; Leitges M; Cohen C; Kay G; Razin E
Blood; 2000 Mar; 95(5):1752-7. PubMed ID: 10688834
[TBL] [Abstract][Full Text] [Related]
13. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.
Zhang J; Shehabeldin A; da Cruz LA; Butler J; Somani AK; McGavin M; Kozieradzki I; dos Santos AO; Nagy A; Grinstein S; Penninger JM; Siminovitch KA
J Exp Med; 1999 Nov; 190(9):1329-42. PubMed ID: 10544204
[TBL] [Abstract][Full Text] [Related]
14. Blockage by SP600125 of Fcepsilon receptor-induced degranulation and cytokine gene expression in mast cells is mediated through inhibition of phosphatidylinositol 3-kinase signalling pathway.
Tanemura S; Momose H; Shimizu N; Kitagawa D; Seo J; Yamasaki T; Nakagawa K; Kajiho H; Penninger JM; Katada T; Nishina H
J Biochem; 2009 Mar; 145(3):345-54. PubMed ID: 19106158
[TBL] [Abstract][Full Text] [Related]
15. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation.
Kawakami Y; Kitaura J; Satterthwaite AB; Kato RM; Asai K; Hartman SE; Maeda-Yamamoto M; Lowell CA; Rawlings DJ; Witte ON; Kawakami T
J Immunol; 2000 Aug; 165(3):1210-9. PubMed ID: 10903718
[TBL] [Abstract][Full Text] [Related]
16. Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells.
Zhang J; Berenstein EH; Evans RL; Siraganian RP
J Exp Med; 1996 Jul; 184(1):71-9. PubMed ID: 8691151
[TBL] [Abstract][Full Text] [Related]
17. Super-oxidized solution inhibits IgE-antigen-induced degranulation and cytokine release in mast cells.
Medina-Tamayo J; Sánchez-Miranda E; Balleza-Tapia H; Ambriz X; Cid ME; González-Espinosa D; Gutiérrez AA; González-Espinosa C
Int Immunopharmacol; 2007 Aug; 7(8):1013-24. PubMed ID: 17570318
[TBL] [Abstract][Full Text] [Related]
18. Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI.
Xiao W; Nishimoto H; Hong H; Kitaura J; Nunomura S; Maeda-Yamamoto M; Kawakami Y; Lowell CA; Ra C; Kawakami T
J Immunol; 2005 Nov; 175(10):6885-92. PubMed ID: 16272347
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of the vav proto-oncogene product links FcepsilonRI to the Rac1-JNK pathway.
Teramoto H; Salem P; Robbins KC; Bustelo XR; Gutkind JS
J Biol Chem; 1997 Apr; 272(16):10751-5. PubMed ID: 9099726
[TBL] [Abstract][Full Text] [Related]
20. Kit and FcepsilonRI mediate unique and convergent signals for release of inflammatory mediators from human mast cells.
Hundley TR; Gilfillan AM; Tkaczyk C; Andrade MV; Metcalfe DD; Beaven MA
Blood; 2004 Oct; 104(8):2410-7. PubMed ID: 15217825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
